ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada · Delayed Price · Currency is CAD 0.4950
+0.0450 (10.00%)
At close: May 6, 2026
ZYUS Life Sciences Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -20.83 | -21.73 | -33.81 | -42.59 | -24.66 | 0.35 |
Depreciation & Amortization | -0.52 | 0 | 0 | 3.11 | 4.05 | - |
Stock-Based Compensation | 0.5 | 0.46 | 0.41 | 0.27 | 0.11 | - |
Other Adjustments | 3.22 | 7.95 | 18.87 | 26.02 | 8.31 | -0.48 |
Change in Receivables | -0.03 | 0.07 | 0.26 | -0.35 | 0.11 | 0.02 |
Changes in Inventories | 0.14 | 0.1 | 0.32 | -0.02 | 0.45 | - |
Changes in Accounts Payable | 2.02 | 1.03 | 0.7 | -5.12 | 2.34 | -0.22 |
Changes in Other Operating Activities | 0.14 | 0.18 | 0.4 | 0.74 | -0.27 | - |
Operating Cash Flow | -7.79 | -9.23 | -9.88 | -17.95 | -9.57 | -0.33 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -0.01 | -0.05 | -0.28 | -0.56 | - |
Sale of Property, Plant & Equipment | - | 0.03 | - | - | - | - |
Purchases of Investments | - | - | 1.87 | -0.06 | - | -0.97 |
Proceeds from Sale of Investments | - | - | - | - | - | 0.39 |
Cash Acquisitions | - | - | - | 4.92 | -0.03 | - |
Other Investing Activities | - | - | - | - | - | 0 |
Investing Cash Flow | 0.01 | 0.01 | 1.83 | 4.58 | -0.59 | -0.58 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | 1.05 | 0.4 | 0.7 | 0.35 | 1.04 | - |
Short-Term Debt Repaid | - | - | -0.6 | -1.09 | -0.1 | - |
Net Short-Term Debt Issued (Repaid) | 1.05 | 0.4 | 0.1 | -0.74 | 0.94 | - |
Long-Term Debt Issued | 0.5 | 3.75 | 5 | 2.45 | 2.05 | - |
Long-Term Debt Repaid | -0.27 | -0.29 | -2 | -2.55 | - | - |
Net Long-Term Debt Issued (Repaid) | 0.23 | 3.46 | 3 | -0.1 | 2.05 | - |
Issuance of Common Stock | 4.07 | 3.79 | 3.31 | 18.44 | 6.88 | - |
Net Common Stock Issued (Repurchased) | 4.07 | 3.79 | 3.31 | 18.44 | 6.88 | - |
Other Financing Activities | -0.12 | -0.11 | -0.44 | -0.46 | -0.24 | - |
Financing Cash Flow | 7.23 | 7.55 | 5.97 | 17.14 | 9.63 | - |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -0.55 | -1.67 | -2.08 | 3.77 | -0.54 | -0.91 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.79 | -9.24 | -9.92 | -18.23 | -10.13 | -0.33 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | 6865.07% | -2281730.00% | -2062790.00% | -5193.45% | -3400.67% | - |
Free Cash Flow Per Share | -0.10 | -0.12 | -0.14 | -0.32 | -0.26 | -0.07 |
Levered Free Cash Flow | -17.78 | -16.57 | -29.32 | -45.01 | -15.67 | 0.13 |
Unlevered Free Cash Flow | -16 | -17.62 | -31.57 | -38.63 | -12.75 | -0.45 |